Skip to content
Screener

Cardinal Health, Inc. CAH Q3 2025 earnings

Reported May 1, 2025 · Before market open

Revenue$54.9BMiss by $512.7M
EPS$2.35Beat by $0.18
Revenue estimate$55.4B
EPS estimate$2.17

Next report

Oct 29, 2026 (in 2 months)
Revenue estimate$66.7B
EPS estimate$2.92

Financials

Q3 2025

Income statement

See full
Revenue$54.9B0.0%
Gross profit$2.1B+9.7%
Operating income$730.0M+97.8%
Net income$506.0M+93.9%
EPS (diluted)$2.10+96.3%

Balance sheet

See full
Cash & equivalents$3.3B-11.2%
Total debt$7.7B+31.2%
Total equity-$2.9B+9.7%
Total assets$49.9B+8.7%

Cash flow

See full
Operating cash flow$2.9B—
CapEx$126.0M+12.5%
Free cash flow$2.8B—

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$33.28B+22.3%
Enterprise value$37.63B+28.3%
P/E21.4×-22.4×
P/S0.1×0.0×

Profitability

See full
Gross margin3.5%+0.2pp
Operating margin1%+0.6pp
Net margin0.7%+0.4pp
FCF margin1.1%+0.1pp

Returns & leverage

See full
Current ratio0.9×0.0×

Segments

By segment

See full
Pharmaceutical and Specialty Solutions$50.4B-0.4%
GMPD$3.2B+1.5%
Other Operating Segment$1.3B+13.0%

By geography

See full
United States$54.5B—

FAQ

When did Cardinal Health, Inc. report Q3 2025 earnings?
Cardinal Health, Inc. (CAH) reported Q3 2025 earnings on May 1, 2025 before market open.
What were Cardinal Health, Inc.'s Q3 2025 revenue and EPS?
Cardinal Health, Inc. reported revenue of $54.9B and eps of $2.35 for Q3 2025.
Did Cardinal Health, Inc. beat estimates in Q3 2025?
Revenue missed the consensus estimate of $55.4B by $512.7M. EPS beat the consensus estimate of $2.17 by $0.18.
How did Cardinal Health, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 0.1% from $54.9B a year earlier and eps grew 13.0% from $2.08.
Where can I find Cardinal Health, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0000721371-25-000036) and the 10-Q periodic report (0000721371-25-000038) directly on SEC EDGAR. The filing index links above go to sec.gov.